.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Harvard Business School
Argus Health
Farmers Insurance
Cantor Fitzgerald
Chinese Patent Office
Queensland Health
Baxter
AstraZeneca

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040513

« Back to Dashboard
NDA 040513 describes BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, which is a drug marketed by Sun Pharm Inds, Mallinckrodt Inc, Mayne Pharma Inc, Vintage Pharms, Tedor Pharma Inc, Actavis Labs Ut Inc, Nuvo Pharm Inc, Hikma Pharms, Gilbert Labs, Watson Labs, Graham Dm, Lannett Holdings Inc, Mallinckrodt, Novast Labs Ltd, Mikart, Mirror Pharms Llc, Cnty Line Pharms, Nexgen Pharma, and Able, and is included in twenty-eight NDAs. It is available from fifty suppliers. Additional details are available on the BUTALBITAL, ACETAMINOPHEN AND CAFFEINE profile page.

The generic ingredient in BUTALBITAL, ACETAMINOPHEN AND CAFFEINE is acetaminophen; butalbital; caffeine. There are sixty-six drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine profile page.

Summary for 040513

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 040513

Suppliers and Packaging for NDA: 040513

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
acetaminophen; butalbital; caffeine
TABLET;ORAL 040513 ANDA STAT RX USA LLC 16590-581 16590-581-30 30 TABLET in 1 BOTTLE (16590-581-30)
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
acetaminophen; butalbital; caffeine
TABLET;ORAL 040513 ANDA STAT RX USA LLC 16590-581 16590-581-60 60 TABLET in 1 BOTTLE (16590-581-60)

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength500MG;50MG;40MG
Approval Date:Aug 25, 2003TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Cantor Fitzgerald
Cerilliant
Chubb
Moodys
Federal Trade Commission
Boehringer Ingelheim
McKinsey
Queensland Health
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot